Trial Profile
A Phase I, Open-label, Fixed-order, Single-dose, 2-Part, Crossover Study to Evaluate the Pharmacokinetics of a Formulation of Tricaprilin (AC-SD-01) Including the Effect of Food on Ketone Body Production in Caucasians and Asians
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Oct 2018
At a glance
- Drugs Tricaprilin (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Cerecin
- 04 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 20 Aug 2018 New trial record